Comments
GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 20, 2019, inter alia, to consider, approval of audited financial results (Standalone & Consolidated) for the quarter / year ended March 31, 2019 and to recommend dividend, if any, on the equity shares of the Company.
Pdf Link: Glaxosmithkline Pharmaceuticals Ltd. - Board to consider FY19 results & Dividend on May 20, 2019
Source : BSE - www.bseindia.com
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.